CONCLUSIONS: Prenatal exposure to stimulants or atomoxetine for attention-deficit/hyperactivity disorder was not associated with increased adjusted risk of major congenital malformations or most adverse pregnancy, perinatal, and neurodevelopmental outcomes. Attenuation of crude associations after adjustment suggests confounding by indication, residual confounding, and maternal characteristics. The observed associations between methylphenidate and cardiovascular malformations and between exposure…
